Is doxycycline safe to use concomitantly with levetiracetam (Keppra)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Is Doxycycline Safe with Keppra (Levetiracetam)?

Yes, doxycycline is safe to use with Keppra (levetiracetam) - there are no clinically significant drug interactions between these medications.

Evidence for Safety

The FDA label for Keppra explicitly addresses drug interactions and provides clear reassurance 1. Levetiracetam has an exceptionally favorable drug interaction profile because it is not metabolized by the liver's cytochrome P450 system, does not undergo hepatic glucuronidation, and circulates largely unbound to plasma proteins (<10% bound). This means it neither affects nor is affected by most other medications, including antibiotics like doxycycline.

Key Pharmacokinetic Points

  • No enzyme interactions: Levetiracetam is not an inhibitor or substrate of cytochrome P450 enzymes, epoxide hydrolase, or UDP-glucuronidation enzymes 1
  • Minimal protein binding: With <10% protein binding, competition for binding sites with other drugs is not a concern 1
  • Non-hepatic metabolism: Approximately 66% is excreted unchanged in urine, and the remaining 34% is metabolized primarily in blood by hydrolysis, not in the liver 2

Clinical Trial Data

Multiple phase III trials specifically evaluated levetiracetam's interaction potential with other medications 3. The FDA label documents that levetiracetam was studied with phenytoin, valproate, oral contraceptives, digoxin, warfarin, and probenecid without clinically significant interactions 1. While doxycycline wasn't specifically studied, the mechanism-based evidence makes interactions highly unlikely.

Practical Considerations

You can prescribe these medications together without dose adjustments. However, be aware of:

  • Doxycycline-specific precautions from CDC guidelines 4: Take with food and a full glass of liquid, avoid lying down for 1 hour after dosing to prevent esophagitis, and separate from dairy products, antacids, and supplements containing calcium, iron, magnesium, or sodium bicarbonate by at least 2 hours
  • Levetiracetam monitoring: Watch for neuropsychiatric side effects (though incidence is low at 3.6% in recent data 5), but these are unrelated to doxycycline co-administration

Bottom Line

The combination is safe because levetiracetam's unique pharmacokinetic profile makes it one of the least interactive antiepileptic drugs available 2, 6. No dosage adjustments or special monitoring beyond standard care for each individual medication is required.

Related Questions

What is the initial dosing of levetiracetam (Keppra) for a young adult woman with normal renal function and no interacting medications?
My Keppra (levetiracetam) level is 52 µg/mL (therapeutic range 10‑40 µg/mL) while I am taking 500 mg twice daily; what dose adjustment should I make?
How should levetiracetam (Keppra) 750 mg IV be converted to an oral dosing regimen?
What is the generic name of Keppra (levetiracetam)?
What laboratory tests should be ordered for a patient on levetiracetam (Keppra)?
What is the chromosomal designation (karyotype) for Turner syndrome?
How might hereditary hemochromatosis (HH) impact the management of Attention‑deficit/hyperactivity disorder (ADHD)?
When should a GLP‑1 receptor agonist be started and at what dose in an adult with type 2 diabetes needing additional glucose lowering and weight loss, without personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2, and who can tolerate subcutaneous injections?
What is the appropriate pre‑operative antimicrobial prophylaxis for clean‑contaminated urologic procedures such as transurethral resection of the prostate, ureteroscopy, percutaneous nephrolithotomy, and bladder stone removal?
What are the causes of warm bilateral pitting edema associated with normocytic anemia?
What is the latest International Pediatric Nephrology Association (IPNA) and International Society of Nephrology (ISN) protocol for managing IgA nephritis in a patient who is non‑responsive to oral steroids and angiotensin‑converting enzyme (ACE) inhibitor therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.